Increased TACE (Tumor necrosis factor-alpha +/--converting enzyme; ADAM17) Activity Associates with Decreased CD62L Expression, Increased Soluble CD62L Plasma Levels and Predicts Molecular Response to Nilotinib Therapy in Patients with Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) : Results from an ENEST1st Substudy

Sopper, Sieghart (author)

Med Univ Innsbruck, Internal Med 5, A-6020 Innsbruck, Austria.;Med Univ Innsbruck, Tyrolean Canc Res Inst TKFI, A-6020 Innsbruck, Austria.

Mustjoki, Satu (author)

Univ Helsinki, Dept Hematol, HRUH, Helsinki, Finland.;Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland.

Loskog, Angelica (author)

Uppsala universitet,Klinisk immunologi

show more...

Gjertsen, Bjorn T. (author)

Univ Bergen, Inst Med, Hematol Sect, Bergen, Norway.

Gastl, Guenther A. (author)

Med Univ Innsbruck, Internal Med 5, Haematol & Oncol, A-6020 Innsbruck, Austria.

Giles, Frank (author)

Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, NMDTI, Chicago, IL 60611 USA.

Hochhaus, Andreas (author)

Univ Klinikum Jena, Abt Hamatol & Internist Onkol, Klin Innere Med 2, Jena, Germany.

Ossenkoppele, Gert J. (author)

Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands.

Porkka, Kimmo (author)

Univ Helsinki, Hematol Res Unit Helsinki, Helsinki, Finland.;Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland.

Wolf, Domink (author)

Univ Clin Bonn, Internal Med 3, Oncol Hematol & Rheumatol, Bonn, Germany.

show less...

Med Univ Innsbruck, Internal Med 5, A-6020 Innsbruck, Austria;Med Univ Innsbruck, Tyrolean Canc Res Inst TKFI, A-6020 Innsbruck, Austria. Univ Helsinki, Dept Hematol, HRUH, Helsinki, Finland.;Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland. (creator_code:org_t)

2015

2015

English.

In: Blood. - 0006-4971 .- 1528-0020. ; 126:23

Related links:

https://urn.kb.se/re...

• Journal article (other academic/artistic)